Diagnosis and treatment of chronic pelvic pain syndrome
Abstract
The management of patients with chronic pelvic pain (CPP) is a serious problem, the solution of which is in the complex interdisciplinary approach. The article describes the neurological aspects of the disease, including musculoskeletal and neurogenic causes of pain. Treatment of patients should be aimed at both the anatomical cause of pain and the correction of emotional disorders. Education and patient involvement in the treatment program are important. In the presence of a nociceptive source of pain in the form of myofascial or joint pain, treatment is carried out in accordance with general recommendations for the treatment of musculoskeletal pain and includes non-steroidal anti-inflammatory drugs and myorelaxants administration. We present our own clinical observation, which reflects a comprehensive approach to the treatment of a patient with CPP.
About the Authors
L. T. Akhmedzhanova
Department of Nervous Diseases and Neurosurgery, N.V. Sklifosovsky Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
Russian Federation
Competing Interests:
Russian Federation
Luiza Talgatovna Akhmedzhanova
119021, Moscow, Rossolimo St., 11, Build. 1
Competing Interests:
The conflict of interest has not affected the results of the investigation.
A. N. Barinov
Department of Neurology and Psychotherapy, Medical Academy JSC Group of Companies “Medsi”
Russian Federation
Competing Interests:
Russian Federation
123056, Moscow, Gruzinsky Lane, 3A
Competing Interests:
The conflict of interest has not affected the results of the investigation.
M. S. Leontyeva
Department of Nervous Diseases and Neurosurgery, N.V. Sklifosovsky Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
Russian Federation
Competing Interests:
Russian Federation
119021, Moscow, Rossolimo St., 11, Build. 1
Competing Interests:
The conflict of interest has not affected the results of the investigation.
E. V. Mandra
Department of Nervous Diseases and Neurosurgery, N.V. Sklifosovsky Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
Russian Federation
Competing Interests:
Russian Federation
119021, Moscow, Rossolimo St., 11, Build. 1
Competing Interests:
The conflict of interest has not affected the results of the investigation.
References
1. Siqueira-Campos VM, de Deus MSC, Poli-Neto OB, et al. Current Challenges in the Management of Chronic Pelvic Pain in Women: From Bench to Bedside. Int J Womens Health. 2022 Feb;14:225-44. doi:10.2147/IJWH.S224891
2. Lamvu G, Carrillo J, Ouyang C, Rapkin A. Chronic Pelvic Pain in Women: A Review. JAMA. 2021 Jun;325(23):2381-91. doi:10.1001/jama.2021.2631
3. Till SR, As-Sanie S, Schrepf A. Psychology of Chronic Pelvic Pain: Prevalence, Neurobiological Vulnerabilities, and Treatment. Clin Obstet Gynecol. 2019 Mar;62(1):22-36. doi:10.1097/GRF.0000000000000412
4. Huang X, Qin Z, Cui H, et al. Psychological factors and pain catastrophizing in men with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): a meta-analysis. Transl Androl Urol. 2020 Apr;9(2):485-93. doi:10.21037/tau.2020.01.25
5. Kryuchkova MN, Soldatkin VA. Chronic pelvic pain syndrome: a psychopathological aspects. Vestnik urologii = Urology Herald. 2017;5(1):52-63. doi:10.21886/2308-6424-2017-5-1-52-63 (In Russ.)
6. Magri V, Marras E, Restelli A, et al. Multimodal therapy for category III chronic prostatitis/chronic pelvic pain syndrome in UPOINTS phenotyped patients. Exp Ther Med. 2015 Mar;9(3):658-66. doi:10.3892/etm.2014.2152
7. Chronic Pelvic Pain: ACOG Practice Bulletin, Number 218. Obstet Gynecol. 2020 Mar;135(3):e98-e109. doi:10.1097/AOG.0000000000003716
8. Ross V, Detterman C, Hallisey A. Myofascial Pelvic Pain: An Overlooked and Treatable Cause of Chronic Pelvic Pain. J Midwifery Womens Health. 2021 Mar;66(2):148-60. doi:10.1111/jmwh.13224
9. Cameron B, Sabourin J, Sanaee MS, et al. Pelvic floor hypertonicity in women with pelvic floor disorders: A case control and risk prediction study. Neurourol Urodyn. 2019 Feb;38(2):696-702. doi:10.1002/nau.23896
10. Jarrell JF, Vilos GA, Allaire C, et al. No. 164-Consensus Guidelines for the Management of Chronic Pelvic Pain. J Obstet Gynaecol Can. 2018 Nov;40(11):e747-e787. doi:10.1016/j.jogc.2018.08.015
11. Elkadry E, Moynihan L. Clinical manifestations and diagnosis of myofascial pelvic pain syndrome in women. In: Post TW, ed. UpTo-Date. Waltham, MA: UpToDate; 2019. Accessed May 2022. Available from: https://www.uptodate.com
12. Dubossarskaja JuA, Dubossarskaja ZM. Chronic pelvic pain syndrome at the level of interdisciplinary communication. Medicinskie aspekty zdorov'ja zhenshhiny = Medical Aspects of a Woman's Health. 2013;3(67):5-16 (In Russ.)
13. Klotz SGR, Ketels G, Löwe B, Brünahl CA. Myofascial Findings and Psychopathological Factors in Patients with Chronic Pelvic Pain Syndrome. Pain Med. 2020 Feb;21(2):e34-e44. doi:10.1093/pm/pny097
14. Kruglov VA, Asfandiyarov FR, Vybornov SN, Seyidov KS. Treatment of patients with chronic pelvic pain syndrome: result of single-center follow up study. Vestnik urologii = Urology Herald. 2018;6(4):27-35. doi:10.21886/2308-6424-2018-6-4-27-35 (In Russ.)
15. Hopayian K, Danielyan A. Four symptoms define the piriformis syndrome: an updated systematic review of its clinical features. Eur J Orthop Surg Traumatol. 2018 Feb;28(2):155-64. doi:10.1007/s00590-017-2031-8
16. Probst D, Stout A, Hunt D. Piriformis Syndrome: A Narrative Review of the Anatomy, Diagnosis, and Treatment. PM R. 2019 Aug;11(1):S54-S63. doi:10.1002/pmrj.12189
17. Bonder JH, Chi M, Rispoli L. Myofascial Pelvic Pain and Related Disorders. Phys Med Rehabil Clin N Am. 2017 Aug;28(3):501-15. doi:10.1016/j.pmr.2017.03.005
18. Wolff BJ, Joyce CJ, Brincat CA, et al. Pelvic floor myofascial pain in patients with symptoms of urinary tract infection. Int J Gynaecol Obstet. 2019 May;145(2):205-11. doi:10.1002/ijgo.12784
19. Neville CE, Carrubba AR, Li Z, et al. Association of coccygodynia with pelvic floor symptoms in women with pelvic pain. PM R. 2021 Sep. doi:10.1002/pmrj.12706. Online ahead of print.
20. Elkhashab Y, Ng A. A Review of Current Treatment Options for Coccygodynia. Curr Pain Headache Rep. 2018 Mar;22(4):28. doi:10.1007/s11916-018-0683-7
21. Kwon HD, Schrot RJ, Kerr EE, Kim KD. Coccygodynia and coccygectomy. Korean J Spine. 2012 Dec;9(4):326-33. doi:10.14245/kjs.2012.9.4.326
22. Solokha OA, Аkhmedzhanova LT, Kuzminova TI, Lavrenenko DS. Back pain: from diagnosis to treatment. Meditsinskiy sovet = Medical Council. 2020;(2):34-42. doi:10.21518/2079-701X-2020-2-34-42 (In Russ.)
23. Izvozchikov SB, Kamchatnov PR, Selitskiy GV. Chronic pelvic pain syndrome – modern look to the problem. Klinitsist = The Clinician. 2011;5(2):62-7. doi:10.17650/1818-8338-2011-2-62-67 (In Russ.)
24. Maigne JY, Lagauche D, Doursounian L. Instability of the coccyx in coccydynia. J Bone Joint Surg Br. 2000 Sep;82(7):1038-41. doi:10.1302/0301-620x.82b7.10596
25. Labat JJ, Riant T, Robert R, et al. Diagnostic criteria for pudendal neuralgia by pudendal nerve entrapment (Nantes criteria). Neurourol Urodyn. 2008;27(4):306-10. doi:10.1002/nau.20505
26. Kohan L, McKenna C, Irwin A. Ilioinguinal Neuropathy. Curr Pain Headache Rep. 2020 Jan;24(1):2. doi:10.1007/s11916-020-0833-6.
27. Barinov AN. Diagnosis and treatment of pelvic pain. Meditsinskiy sovet = Medical Council. 2015;(10):66-76. doi:10.21518/2079-701X2015-10-66-76 (In Russ.)
28. Drakonaki EE, Adriaensen MEAPM, Al-Bulushi HIJ, et al. Sonoanatomy of the ilioinguinal, iliohypogastric, genitofemoral, obturator, and pudendal nerves: a practical guide for US-guided injections. J Ultrason. 2022 Feb;22(88):e44-e50. doi:10.15557/JoU.2022.0008
29. Poh F, Xi Y, Rozen SM, et al. Neurography in Groin and Genital Pain: Ilioinguinal, Iliohypogastric, and Genitofemoral Neuralgia. AJR Am J Roentgenol. 2019 Mar;212(3):632-43. doi:10.2214/AJR.18.20316
30. Miller-Matero LR, Saulino C, Clark S, et al. When treating the pain is not enough: a multidisciplinary approach for chronic pelvic pain. Arch Womens Ment Health. 2016 Apr;19(2):349-54. doi:10.1007/s00737-015-0537-9
31. Twiddy H, Lane N, Chawla R, et al. The development and delivery of a female chronic pelvic pain management programme: a specialised interdisciplinary approach. Br J Pain. 2015 Nov;9(4):233-40. doi:10.1177/2049463715584408
32. Lumley MA, Schubiner H. Psychological Therapy for Centralized Pain: An Integrative Assessment and Treatment Model. Psychosom Med. 2019 Mar;81(2):114-24. doi:10.1097/PSY.0000000000000654
33. Wijma AJ, van Wilgen CP, Meeus M, Nijs J. Clinical biopsychosocial physiotherapy assessment of patients with chronic pain: The first step in pain neuroscience education. Physiother Theory Pract. 2016 Jul;32(5):368-84. doi:10.1080/09593985.2016.1194651
34. Brünahl CA, Klotz SGR, Dybowski C, et al. Combined Cognitive-Behavioural and Physiotherapeutic Therapy for Patients with Chronic Pelvic Pain Syndrome (COMBI-CPPS): study protocol for a controlled feasibility trial. Trials. 2018 Jan;19(1):20. doi:10.1186/s13063-017-2387-4
35. Grinberg K, Sela Y, Nissanholtz-Gannot R. New Insights about Chronic Pelvic Pain Syndrome (CPPS). Int J Environ Res Public Health. 2020 Apr;17(9):3005. doi:10.3390/ijerph17093005
36. Rachin SA, Sharov MN, Zaitsev AV, et al. Chronic pelvic pain: from correct diagnosis to adequate therapy. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2020;12(2):12-6. doi:10.14412/2074-2711-2020-2-12-16 (In Russ.)
37. Goncalves AV, Barros NF, Bahamondes L. The Practice of Hatha Yoga for the Treatment of Pain Associated with Endometriosis. J Altern Complement Med. 2017 Jan;23(1):45-52. doi:10.1089/acm.2015.0343
38. Saxena R, Gupta M, Shankar N, et al. Effects of yogic intervention on pain scores and quality of life in females with chronic pelvic pain. Int J Yoga. 2017 Apr;10(1):9-15. doi:10.4103/0973-6131.186155
39. Geneen LJ, Moore RA, Clarke C, et al. Physical activity and exercise for chronic pain in adults: an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2017 Jan;1(1):CD011279. doi:10.1002/14651858.CD011279.pub2
40. Dooley M, Spencer CM, Dunn CJ. Aceclofenac: a reappraisal of its use in the management of pain and rheumatic disease. Drugs. 2001;61(9):1351-78. doi:10.2165/00003495-200161090-00012
41. Patel PB, Patel TK. Efficacy and safety of aceclofenac in osteoarthritis: A meta-analysis of randomized controlled trials. Eur J Rheumatol. 2017 Mar;4(1):11-8. doi:10.5152/eurjrheum.2017.160080
42. Castellsague J, Riera-Guardia N, Calingaert B, et al. Safety of Non-Steroidal Anti-Inflammatory Drugs (SOS) Project. Individual NSAIDs and upper gastrointestinal complications: a systematic review and metaanalysis of observational studies (the SOS project). Drug Saf. 2012 Dec;35(12):1127-46. doi:10.2165/11633470-000000000-00000
43. Cherevatenko RF. The role of aceclofenac (Aertal) in the complex treatment of nonspecific lumbalgia. Khirurgija. Zhurnal im. N.I. Pirogova = Surgery. Journal named after N.I. Pirogov. 2018;(12):96-9. doi:10.17116/hirurgia201812196 (In Russ.)
44. Letzel H, Megard Y, Lamarca R, et al. The efficacy and safety of aceclofenac versus placebo and naproxen in women with primary dysmenorrhoea. Eur J Obstet Gynecol Reprod Biol. 2006 Dec;129(2):162-8. doi:10.1016/j.ejogrb.2006.01.004
45. Parfenov VA, Bogdanov EI, Laskov VB, et al. Multicenter, randomized, double-blind study of the efficacy and safety of prolonged release tolperisone hydrochloride 450 mg (Mydocalm® Long, once daily) and tolperisone hydrochloride 150 mg (three times daily) for acute nonspecific lower back pain. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2021;13(6):14-22. doi:10.14412/2074-2711-2021-6-14-22 (In Russ.)
46. Sator-Katzenschlager SM, Scharbert G, Kress HG, et al. Chronic pelvic pain treated with gabapentin and amitriptyline: a randomized controlled pilot study. Wien Klin Wochenschr. 2005 Nov;117(21-22):761-8. doi:10.1007/s00508-005-0464-2
47. Lewis SC, Bhattacharya S, Wu O, et al. Gabapentin for the Management of Chronic Pelvic Pain in Women (GaPP1): A Pilot Randomised Controlled Trial. PLoS One. 2016 Apr;11(4):e0153037. doi:10.1371/journal.pone.0153037
48. Horne AW, Vincent K, Hewitt CA, et al. Gabapentin for chronic pelvic pain in women (GaPP2): a multicentre, randomised, doubleblind, placebo-controlled trial. Lancet. 2020 Sep;396(10255):909-17. doi:10.1016/S0140-6736(20)31693-7
Review
Supporting agencies: This article has been supported by Gedeon Richter.
For citations:
Akhmedzhanova L.T., Barinov A.N., Leontyeva M.S., Mandra E.V. Diagnosis and treatment of chronic pelvic pain syndrome. Neurology, Neuropsychiatry, Psychosomatics. 2022;14(4):54-61. (In Russ.) https://doi.org/10.14412/2074-2711-2022-4-54-61
Views: 180
Email this article 